| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3340187 | Allergologia et Immunopathologia | 2008 | 7 Pages |
Abstract
Both scoring systems for AD are valid, reproducible and responsive in monitoring AD patients. Further studies will be necessary to investigate the development of AD and the best evaluation. SCORAD showed itself to be an excellent score to detect the development of AD, whereas the EASI are suitable to follow up in drug-effect studies of AD for research purposes.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
V.E.V. Rullo, A. Segato, A. Kirsh, D. Sole,